Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash & Equivalents: 2020-2025

Historic Cash & Equivalents for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to $73.3 million.

  • Incannex Healthcare's Cash & Equivalents rose 1920.95% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year increase of 1920.95%. This contributed to the annual value of $15.0 million for FY2025, which is 154.90% up from last year.
  • Incannex Healthcare's Cash & Equivalents amounted to $73.3 million in Q3 2025, which was up 387.40% from $15.0 million recorded in Q2 2025.
  • Incannex Healthcare's 5-year Cash & Equivalents high stood at $73.3 million for Q3 2025, and its period low was $2.1 million during Q4 2024.
  • In the last 3 years, Incannex Healthcare's Cash & Equivalents had a median value of $8.0 million in 2024 and averaged $16.3 million.
  • Per our database at Business Quant, Incannex Healthcare's Cash & Equivalents crashed by 85.58% in 2024 and then skyrocketed by 1,920.95% in 2025.
  • Over the past 3 years, Incannex Healthcare's Cash & Equivalents (Quarterly) stood at $14.6 million in 2023, then plummeted by 85.58% to $2.1 million in 2024, then soared by 1,920.95% to $73.3 million in 2025.
  • Its Cash & Equivalents was $73.3 million in Q3 2025, compared to $15.0 million in Q2 2025 and $6.7 million in Q1 2025.